Early 2026 marijuana legislation is quietly rewriting the risk calculus for employers that still rely on zero‑tolerance drug testing rules. New bills in Mississippi split full adult‑use legalization from the simple act of rescheduling cannabis, underscoring how legal status can shift even without a commercial market. Hawaii is pressing ahead on two fronts—comprehensive legalization bills and a proposed 2026 voter referendum—while simultaneously modernizing its medical marijuana infrastructure. Nebraska, pushed by voters, is racing to operationalize medical cannabis while preserving formal employer discretion, a model that still strains hiring and accommodation practices. Meanwhile, Congress has delayed tighter hemp rules, prolonging confusion when legal hemp use triggers positive tests. As Alonzo Martinez argues in Forbes, employers that wait for perfect clarity, rather than updating policies now, may face the steepest compliance and litigation risks.
The latest news on the legalization of controversial botanicals.
